WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

The Patent Term Compensation and Protection Sc... (2/25/2026)

After 230% Deal Size Explosion, China Is No Lo... (2/24/2026)

China Biotech Kicks Off 2026 with $863 Million... (2/20/2026)

Long-Acting Obesity Drugs Drive Record January... (2/16/2026)

China's Innovation in Translational Medicine: ... (2/16/2026)

China Biotech Dealmaking and Financing Stay St... (2/13/2026)

China NMPA Approves Nine New Drugs in January ... (2/12/2026)

Today's China Crucible: What It Means for Phar... (2/12/2026)

China Overhauls Drug Administration Rules, Emp... (2/10/2026)

China Biotech Lights Up. U.S. Stocks Prepare F... (2/10/2026)

Global Pharma in 2025: China Remains a Key Mar... (2/5/2026)

China Biotech Emerges as Global Deal Powerhous... (2/5/2026)

CASI Pharma to Be Delisted from Nasdaq, ... (2/25/2026) CDE Solicits Comments on Batch 104 of Ch... (2/25/2026) Kelun-Biotech's sac-TMT OS Data Selected... (2/25/2026) Shanghai's Prodegre Closes Angel+ Round ... (2/25/2026) Slate Medicines Launches With $130M to A... (2/25/2026) Henlius Expands Global Footprint with Ex... (2/25/2026) Biokin's Iza-Bren Achieves Second Phase ... (2/24/2026) China Prepares to Implement Landmark Reg... (2/24/2026) CDE Issues Guidelines on Benefit-Risk As... (2/24/2026) CDE Releases Q&A Document on Development... (2/24/2026) CDE Issues Guideline on Clinical Informa... (2/24/2026) Huadong Launches Head-to-Head Phase III ... (2/24/2026) GenSci Advances PD-1 Agonist Into Phase ... (2/24/2026) Ascentage Registers U.S. Phase 1 Trial f... (2/24/2026) Harbour BioMed Strikes $1.1B-Plus Ex-Chi... (2/24/2026) Frontier Biotech Inks Global siRNA Licen... (2/24/2026) XtalPi and YolTech Forge AI Alliance to ... (2/24/2026) United Labs and Novo Nordisk Post Strong... (2/24/2026)

China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E...

Henlius Expands Global Footprint with Exclusive Abbott ... Slate Medicines Launches With $130M to Advance China-Li... Shanghai's Prodegre Closes Angel+ Round to Advance CNS ... CASI Pharma to Be Delisted from Nasdaq, Shares to Move ... Pfizer Acquires China Rights to Sciwind's Approved GLP-...

CDE Solicits Comments on Batch 104 of Chemical Generic ... CDE Issues Guideline on Clinical Information for CAR-T ... CDE Releases Q&A Document on Development Safety Update ... CDE Issues Guidelines on Benefit-Risk Assessment Using ... China Prepares to Implement Landmark Regulations for Cl...

NHSA Issues Trial Measures for Early Communication on R... China Issues Revised Rules for National Essential Drug ... China Moves to Accelerate New Healthcare Insurance Mode... China Launches Nationwide Crackdown on BMI Fraud in Men... China's Health Insurance Market Poised for $596B Surge ...

Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa... Roche and Henlius–Organon Resolve U.S. Patent Dispute ... China Warns of Foreign Misuse of Research Ties to Acces... China's Supreme Court Upholds Semaglutide Patent, Stren...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

Kelun-Biotech's sac-TMT OS Data Selected as Late-Breake... United Labs and Novo Nordisk Post Strong Phase 2 Data f... Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC A... GenSci Advances PD-1 Agonist Into Phase 2b for Rheumato... Huadong Launches Head-to-Head Phase III Trial for Dual ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...